Suscripción a Biblioteca: Guest
Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones
Critical Reviews™ in Therapeutic Drug Carrier Systems
Factor de Impacto: 2.9 Factor de Impacto de 5 años: 3.72 SJR: 0.573 SNIP: 0.551 CiteScore™: 2.43

ISSN Imprimir: 0743-4863
ISSN En Línea: 2162-660X

Volumen 36, 2019 Volumen 35, 2018 Volumen 34, 2017 Volumen 33, 2016 Volumen 32, 2015 Volumen 31, 2014 Volumen 30, 2013 Volumen 29, 2012 Volumen 28, 2011 Volumen 27, 2010 Volumen 26, 2009 Volumen 25, 2008 Volumen 24, 2007 Volumen 23, 2006 Volumen 22, 2005 Volumen 21, 2004 Volumen 20, 2003 Volumen 19, 2002 Volumen 18, 2001 Volumen 17, 2000 Volumen 16, 1999 Volumen 15, 1998 Volumen 14, 1997 Volumen 13, 1996 Volumen 12, 1995

Critical Reviews™ in Therapeutic Drug Carrier Systems

DOI: 10.1615/CritRevTherDrugCarrierSyst.v21.i2.10
30 pages

Caveolae—An Alternative Endocytotic Pathway for Targeted Drug Delivery

Gyorgy Bathori
Department of Physiology, Semmelweis University, Budapest, Hungary
Laszlo Cervenak
Third Department of Internal Medicine, Semmelweis University, Budapest, Hungary
Istvan Karadi
Third Department of Internal Medicine, Semmelweis University, Budapest, Hungary


Caveolae are bottleshape-like invaginations of the plasma membrane. After internalization they are involved in endocytosis, transcytosis, potocytosis, and pinocytosis. Our recently expanded knowledge has made clear that various molecules and macromolecular complexes enter the cells after docking on caveolar receptors, before subsequent internalization of the caveolae. The internalization is initiated by the ligand receptor interaction. Folate, cholesterol, serum lipoproteins, and liposomes are among the most common examples. It is important to point out that, in contrast to the classic clathrin-dependent endocytosis, the caveolar internalization pathway seems to avoid the lysosomes. Internalized caveolae fuse with caveosomes, and the caveosomes deliver their contents into other subcellular (non-lysosomal) compartments. The bypass of the acidic and harmful milieu might be a major advantage for drug delivery via the caveolar pathway. Not all cell types have caveolae. Cells, where the Caveolin I protein is not expressed, do not develop caveolar invaginations. However, these cells have caveolar-equivalent plasma membrane domains, so-called "lipid rafts." Lipid rafts are assembled from the same lipid constituents and proteins as caveolae, but they are flat. Specific ligands may also dock on appropriate receptors of the raft domain. As a complication, certain types of ligand-covered raft receptors can migrate to clathrin-coated pits and get internalized via clathrin-coated vesicles. Nevertheless, suitable ligands or antibodies developed against proteins of the caveolar/raft domains may selectively direct the attached drug carrier to the less harmful caveolar/raft pathway. Thus, understanding of caveolar transport may help in the rational design of more effective drug carriers.

Articles with similar content:

Human TCR as Antigen: Homologies and Potentially Cross-Reactive HLA-DR2-Restricted Epitopes Within the AV and BV CDR2 Loops
Critical Reviews™ in Immunology, Vol.20, 2000, issue 1
Arthur A. Vandenbark, Halina Offner, Abigail Buenafe, David Barnes, Gregory G. Burrows, Sandra Law, Yuan K. Chou, Tom Finn, Nicole Culbertson
Targeted Gene Delivery: A Two-Pronged Approach
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.17, 2000, issue 4
Austin Bailey, Sean M. Sullivan, Khursheed Anwer
Lipoproteins: From Physiological Roles to Drug Delivery Potentials
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.23, 2006, issue 6
Abdolhossein Zarrin, Mehrdad Hamidi, Mahshid Foroozesh
Ligand-Receptor-Mediated Drug Delivery: An Emerging Paradigm in Cellular Drug Targeting
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.18, 2001, issue 1
Suresh P. Vyas, V. Sihorkar, Amarjit Singh
Exosomes, Ectosomes and the Two Together. Physiology and Pathology
Forum on Immunopathological Diseases and Therapeutics, Vol.6, 2015, issue 3-4
Jacopo Meldolesi